REG - Tern PLC - Investor Presentations

TernAnnouncement

08/01/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260108:nRSH0746Oa&default-theme=true

RNS Number : 0746O  Tern PLC  08 January 2026

8 January 2026

 

Tern Plc

("Tern" or the "Company")

Investor Presentations

Tern Plc (AIM:TERN), the investment company specialising in supporting high
growth, early-stage, disruptive Internet of Things ("IoT") technology
businesses, is pleased to announce that following its online presentation and
a Q&A session yesterday evening involving Tern's portfolio companies
Device Authority and Talking Medicines, copies of the presentations from the
participating companies can be found via the links below:

 

Device Authority presentation:
 http://www.rns-pdf.londonstockexchange.com/rns/0746O_1-2026-1-7.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/0746O_1-2026-1-7.pdf)

Talking Medicines presentation:
 http://www.rns-pdf.londonstockexchange.com/rns/0746O_2-2026-1-7.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/0746O_2-2026-1-7.pdf)

 

In addition a recording of the event will shortly be available to view on the
Company's website at: https://www.ternplc.com/resources
(https://www.ternplc.com/resources)

 

Enquiries

 

 Tern Plc                                           via IFC Advisory

 Jane McCracken (Interim Non-Executive Chair)

 Allenby Capital Limited                            Tel: 0203 328 5656

 (Nominated Adviser and Broker)

 Alex Brearley / Ashur Joseph (Corporate Finance)

 Kelly Gardiner (Sales and Corporate Broking)

 IFC Advisory                                       Tel: 0203 934 6632

 (Financial PR and IR)

 Tim Metcalfe

 Graham Herring

 Florence Staton

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCBRMLTMTAMBRF



            Copyright 2019 Regulatory News Service, all rights reserved